As of 2025-12-15, the Relative Valuation of Anika Therapeutics Inc (ANIK) is (39.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 9.56 USD, the upside of Anika Therapeutics Inc based on Relative Valuation is -509.8%.
The range of the Relative Valuation is (38.03) - (46.51) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.8x - 20.3x | 17.0x |
| Forward P/E multiples | 16.6x - 27.8x | 17.2x |
| Fair Price | (38.03) - (46.51) | (39.18) |
| Upside | -497.8% - -586.5% | -509.8% |
| Date | P/E |
| 2025-12-12 | -4.17 |
| 2025-12-11 | -4.14 |
| 2025-12-10 | -4.21 |
| 2025-12-09 | -4.16 |
| 2025-12-08 | -4.20 |
| 2025-12-05 | -4.19 |
| 2025-12-04 | -4.14 |
| 2025-12-03 | -4.13 |
| 2025-12-02 | -4.12 |
| 2025-12-01 | -4.26 |
| 2025-11-28 | -4.31 |
| 2025-11-26 | -4.27 |
| 2025-11-25 | -4.36 |
| 2025-11-24 | -4.31 |
| 2025-11-21 | -4.31 |
| 2025-11-20 | -4.06 |
| 2025-11-19 | -4.16 |
| 2025-11-18 | -4.22 |
| 2025-11-17 | -4.21 |
| 2025-11-14 | -4.36 |
| 2025-11-13 | -4.41 |
| 2025-11-12 | -4.41 |
| 2025-11-11 | -4.42 |
| 2025-11-10 | -4.40 |
| 2025-11-07 | -4.30 |
| 2025-11-06 | -4.26 |
| 2025-11-05 | -4.30 |
| 2025-11-04 | -4.20 |
| 2025-11-03 | -4.29 |
| 2025-10-31 | -4.26 |
| 2025-10-30 | -4.27 |
| 2025-10-29 | -4.23 |
| 2025-10-28 | -4.25 |
| 2025-10-27 | -4.23 |
| 2025-10-24 | -4.37 |
| 2025-10-23 | -4.21 |
| 2025-10-22 | -4.18 |
| 2025-10-21 | -4.27 |
| 2025-10-20 | -4.21 |
| 2025-10-17 | -4.00 |
| 2025-10-16 | -3.97 |
| 2025-10-15 | -3.97 |
| 2025-10-14 | -3.99 |
| 2025-10-13 | -3.97 |
| 2025-10-10 | -3.94 |
| 2025-10-09 | -4.11 |
| 2025-10-08 | -4.03 |
| 2025-10-07 | -3.97 |
| 2025-10-06 | -4.04 |
| 2025-10-03 | -3.96 |